大幸薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/04/27 | 1,826 | 1,844 | 1,825 | 1,836 | +10 | +0.5% | 18,900 |
| 2017/04/26 | 1,837 | 1,841 | 1,822 | 1,826 | +7 | +0.4% | 15,300 |
| 2017/04/25 | 1,815 | 1,825 | 1,810 | 1,819 | +5 | +0.3% | 27,700 |
| 2017/04/24 | 1,816 | 1,818 | 1,805 | 1,814 | +11 | +0.6% | 27,600 |
| 2017/04/21 | 1,800 | 1,810 | 1,795 | 1,803 | +3 | +0.2% | 27,600 |
| 2017/04/20 | 1,802 | 1,817 | 1,796 | 1,800 | -8 | -0.4% | 39,200 |
| 2017/04/19 | 1,800 | 1,814 | 1,798 | 1,808 | +11 | +0.6% | 40,700 |
| 2017/04/18 | 1,800 | 1,810 | 1,791 | 1,797 | -3 | -0.2% | 29,500 |
| 2017/04/17 | 1,801 | 1,813 | 1,798 | 1,800 | -1 | -0.1% | 24,900 |
| 2017/04/14 | 1,806 | 1,814 | 1,796 | 1,801 | -9 | -0.5% | 38,800 |
| 2017/04/13 | 1,816 | 1,818 | 1,802 | 1,810 | -10 | -0.5% | 30,100 |
| 2017/04/12 | 1,830 | 1,830 | 1,815 | 1,820 | -14 | -0.8% | 43,900 |
| 2017/04/11 | 1,840 | 1,847 | 1,829 | 1,834 | -4 | -0.2% | 37,900 |
| 2017/04/10 | 1,850 | 1,855 | 1,818 | 1,838 | -11 | -0.6% | 37,400 |
| 2017/04/07 | 1,863 | 1,876 | 1,845 | 1,849 | -10 | -0.5% | 55,800 |
| 2017/04/06 | 1,870 | 1,890 | 1,858 | 1,859 | -15 | -0.8% | 60,200 |
| 2017/04/05 | 1,875 | 1,885 | 1,854 | 1,874 | -14 | -0.7% | 29,700 |
| 2017/04/04 | 1,894 | 1,900 | 1,878 | 1,888 | ±0 | ±0% | 36,800 |
| 2017/04/03 | 1,892 | 1,900 | 1,879 | 1,888 | -5 | -0.3% | 31,200 |
| 2017/03/31 | 1,898 | 1,910 | 1,893 | 1,893 | -5 | -0.3% | 39,100 |
| 2017/03/30 | 1,930 | 1,930 | 1,897 | 1,898 | -31 | -1.6% | 32,300 |
| 2017/03/29 | 1,904 | 1,942 | 1,904 | 1,929 | +10 | +0.5% | 94,300 |
| 2017/03/28 | 1,910 | 1,920 | 1,908 | 1,919 | +19 | +1% | 67,900 |
| 2017/03/27 | 1,904 | 1,920 | 1,889 | 1,900 | -3 | -0.2% | 29,800 |
| 2017/03/24 | 1,875 | 1,907 | 1,875 | 1,903 | +34 | +1.8% | 43,000 |
| 2017/03/23 | 1,869 | 1,875 | 1,862 | 1,869 | +5 | +0.3% | 15,600 |
| 2017/03/22 | 1,868 | 1,880 | 1,864 | 1,864 | -22 | -1.2% | 57,800 |
| 2017/03/21 | 1,900 | 1,900 | 1,881 | 1,886 | -17 | -0.9% | 28,000 |
| 2017/03/17 | 1,898 | 1,906 | 1,880 | 1,903 | +8 | +0.4% | 85,800 |
| 2017/03/16 | 1,895 | 1,896 | 1,884 | 1,895 | +1 | +0.1% | 38,600 |
| 2017/03/15 | 1,881 | 1,897 | 1,871 | 1,894 | +13 | +0.7% | 47,500 |
| 2017/03/14 | 1,897 | 1,898 | 1,878 | 1,881 | -16 | -0.8% | 20,800 |
| 2017/03/13 | 1,888 | 1,897 | 1,863 | 1,897 | +12 | +0.6% | 51,200 |
| 2017/03/10 | 1,873 | 1,889 | 1,851 | 1,885 | +32 | +1.7% | 58,500 |
| 2017/03/09 | 1,860 | 1,862 | 1,847 | 1,853 | -7 | -0.4% | 40,700 |
| 2017/03/08 | 1,850 | 1,861 | 1,841 | 1,860 | +6 | +0.3% | 40,800 |
| 2017/03/07 | 1,857 | 1,861 | 1,853 | 1,854 | -13 | -0.7% | 24,900 |
| 2017/03/06 | 1,850 | 1,879 | 1,848 | 1,867 | -2 | -0.1% | 52,500 |
| 2017/03/03 | 1,885 | 1,885 | 1,867 | 1,869 | -16 | -0.8% | 33,000 |
| 2017/03/02 | 1,900 | 1,900 | 1,880 | 1,885 | -12 | -0.6% | 68,400 |
| 2017/03/01 | 1,875 | 1,899 | 1,865 | 1,897 | +17 | +0.9% | 48,800 |
| 2017/02/28 | 1,885 | 1,888 | 1,877 | 1,880 | -4 | -0.2% | 57,400 |
| 2017/02/27 | 1,880 | 1,890 | 1,873 | 1,884 | ±0 | ±0% | 44,000 |
| 2017/02/24 | 1,880 | 1,891 | 1,867 | 1,884 | +4 | +0.2% | 48,900 |
| 2017/02/23 | 1,861 | 1,880 | 1,855 | 1,880 | +9 | +0.5% | 47,900 |
| 2017/02/22 | 1,849 | 1,875 | 1,843 | 1,871 | +33 | +1.8% | 99,500 |
| 2017/02/21 | 1,800 | 1,839 | 1,800 | 1,838 | +41 | +2.3% | 72,500 |
| 2017/02/20 | 1,767 | 1,800 | 1,759 | 1,797 | +31 | +1.8% | 72,300 |
| 2017/02/17 | 1,771 | 1,780 | 1,757 | 1,766 | -1 | -0.1% | 35,000 |
| 2017/02/16 | 1,774 | 1,780 | 1,755 | 1,767 | -16 | -0.9% | 36,200 |
1851～
1900
件表示中 / 3839件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
| セルソース | 111,700円 | -3.0% | -55.9% | 0.45% | 53.06倍 | 3.66倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| ヘリオス | 19,600円 | +395.9% | - | 0.00% | - | 5.45倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| オンコリス | 70,300円 | +58.7% | - | 0.00% | - | 12.39倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
市場注目の銘柄
チャート関連のコラム
